Distribution Intelligence Systems v. Smith & Nephew: Voluntary Dismissal in Suture Anchor Patent Case
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Distribution Intelligence Systems, LLC v. Smith & Nephew, Co. |
| Case Number | 1:24-cv-00223 (W.D. Tex.) |
| Court | U.S. District Court for the Western District of Texas, Chief Judge Robert Pitman |
| Duration | Mar 4, 2024 – Apr 11, 2024 38 days |
| Outcome | Voluntary Dismissal with Prejudice |
| Patents at Issue | |
| Accused Products | Smith & Nephew’s Microraptor Knotless Suture Anchor |
Case Overview
The Parties
⚖️ Plaintiff
A patent assertion entity (PAE) focused on licensing and monetization through litigation, with a focus on medical device patents.
🛡️ Defendant
Globally recognized medical device company with a substantial orthopedic product portfolio, including surgical repair technologies.
The Patent at Issue
This lawsuit centered on U.S. Patent No. 8,617,160 B2, covering technology relating to suture anchor design and deployment. This is a competitive and heavily litigated space given the commercial value of knotless fixation systems in minimally invasive orthopedic surgery.
- • US 8,617,160 B2 — Suture anchor systems for orthopedic and sports medicine surgical procedures.
The Accused Product
Smith & Nephew’s Microraptor Knotless Suture Anchor was the sole identified accused product. Knotless suture anchors are widely used in rotator cuff repair, labral repair, and other soft-tissue procedures, representing a high-revenue product category in the orthopedic device market.
Legal Representation
Plaintiff’s Counsel: Garteiser Honea PLLC represented Distribution Intelligence Systems. This Texas-based firm frequently practices patent infringement litigation in the Western District of Texas.
Defendant’s Counsel: No defense counsel was entered on the docket prior to dismissal, consistent with the pre-answer procedural posture.
Developing new orthopedic devices?
Check if your suture anchor designs might infringe existing patents before launch.
The Verdict & Legal Analysis
Outcome
On April 10, 2024, Distribution Intelligence Systems filed a notice of voluntary dismissal with prejudice under Fed. R. Civ. P. 41(a)(1)(A)(i). The court entered a closing order on April 11, 2024, confirming the case was self-terminating. No damages were awarded, and no injunctive relief was sought or granted.
Rule 41(a)(1)(A)(i) — Procedural Significance
This dismissal mechanism allows a plaintiff to dismiss an action without a court order before the opposing party serves an answer or a motion for summary judgment. Such a notice is “self-effectuating and terminates the case in and of itself; no order or other action of the district court is required” (*In re Amerijet Int’l, Inc.*, 785 F.3d 967, 973 (5th Cir. 2015)).
The dismissal with prejudice is critical here, constituting a final adjudication on the merits. It permanently bars Distribution Intelligence Systems from reasserting the same claims against Smith & Nephew on U.S. Patent No. 8,617,160 B2.
Why Dismiss With Prejudice?
Such an early, with-prejudice dismissal often suggests a strategic calculus reflecting one or more scenarios: a confidential settlement, identification of claim weakness post-filing, or the defendant’s strong early defense posture. Without disclosed terms, the precise motivation remains speculative, but the finality of the dismissal rules out a simple placeholder filing.
Legal Significance
This case does not set binding precedent on substantive patent law, as no claim construction or validity determinations were issued. However, it illustrates a recurring procedural pattern in Non-Practicing Entity (NPE) litigation: rapid assertion followed by an early exit, often signaling either a swift settlement or a strategic reassessment by the plaintiff.
Strategic Takeaways for Litigators
Early, assertive communication of defense posture—even before filing an answer—can materially affect a plaintiff’s litigation calculus. For patent holders, thorough pre-filing infringement analysis is crucial, as with-prejudice dismissals permanently foreclose reassertion, a significant concession.
Freedom to Operate (FTO) Analysis in Medical Devices
This case highlights critical IP risks in the orthopedic device market. Choose your next step:
📋 Understand Suture Anchor Landscape
Learn about related patents and competitive activity in this technology space.
- View 47 related patents in medical device fixation
- See which companies are most active in suture anchor IP
- Understand claim construction patterns for similar technologies
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own medical device product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable infringement risk assessment
High Risk Area
Knotless suture anchor technology
47 Related Patents
In the broader medical device space
Strategic Dismissal
Signals early defense impact or settlement
✅ Key Takeaways
Rule 41(a)(1)(A)(i) dismissals are self-effectuating and permanently bar reassertion if filed with prejudice.
Search related case law →Early, assertive defense communication can materially alter plaintiff’s litigation calculus, even before an answer is filed.
Explore defense strategies →Monitor the knotless suture anchor patent space for continued assertion activity, especially on US 8,617,160 B2 and its family members.
Track patent family status →High-revenue medical device product lines require continuous FTO monitoring and proactive design documentation, not just pre-launch clearance.
Start FTO analysis for my product →Frequently Asked Questions
The case involved U.S. Patent No. 8,617,160 B2 (Application No. US 13/043,173), a medical device patent asserted against Smith & Nephew’s Microraptor Knotless Suture Anchor.
The plaintiff voluntarily dismissed all claims with prejudice under Fed. R. Civ. P. 41(a)(1)(A)(i) before the defendant served any answer or motion for summary judgment, 38 days after filing.
While non-precedential, the case reflects active NPE assertion in the knotless suture anchor space. Companies with competing products should maintain current FTO analyses covering the ‘160 patent family and related orthopedic fixation technology.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
PatSnap IP Intelligence Team
Patent Research & Competitive Intelligence · PatSnap
This analysis was produced by the PatSnap IP Intelligence Team — a group of patent analysts, IP strategists, and data scientists who work daily with PatSnap’s global patent database of over 2 billion structured data points across patents, litigation records, scientific literature, and regulatory filings.
The team specialises in tracking landmark litigation outcomes, translating complex court rulings into actionable IP strategy, and identifying the competitive intelligence implications for R&D and legal teams. All case analysis is grounded in primary sources: official court records, USPTO filings, and Federal Circuit opinions.
References
- USPTO Patent Full-Text Database — US8617160B2
- PACER Case Locator — Case 1:24-cv-00223
- Western District of Texas Local Patent Rules
- Cornell Legal Information Institute — Fed. R. Civ. P. 41(a)
- PatSnap — IP Intelligence Solutions for Law Firms
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.
📑 Table of Contents
🚀 PatSnap Eureka IP Tools
🔍Novelty Search
Find prior art instantly
Patent Drafting
AI-assisted claim writing
FTO Analysis
Assess infringement risk
Concerned About Your Medical Device?
Don’t wait for litigation. Check your product’s freedom to operate now with AI-powered analysis.
Run FTO for My Product